Status:
UNKNOWN
Klotho _ LRP-6 _ Gastric Adenocarcinoma
Lead Sponsor:
Assiut University
Collaborating Sponsors:
South Egypt Cancer Institute
Conditions:
Gastric Adenocarcinoma
Klotho
Eligibility:
All Genders
18-80 years
Brief Summary
Gastric cancer is the fifth most common malignancy in the world after cancers of the lung, breast, colorectum, and prostate. Gastric cancer is the third leading cause of cancer death and is responsibl...
Detailed Description
Gastric cancer is the fifth most common malignancy in the world after cancers of the lung, breast, colorectum, and prostate. Gastric cancer is the third leading cause of cancer death and is responsibl...
Eligibility Criteria
Inclusion
- Patients had a pathological diagnosis of gastric adenocarcinoma.
- Staging, lymph node (LN) metastasis and overall survival (OS) were analyzed according to Klotho and LRP-6 expression status.
Exclusion
- Gastric Tumors other than adenocarcinoma.
- Cases with loss records files.
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05293535
Start Date
April 1 2023
End Date
April 1 2024
Last Update
January 31 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.